A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma

Published:2019 Issue:11 Volume:60 Page:1013
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Shi Shanping¹^ORCID,Ye Shazhou¹^ORCID,Wu Xiaoyue¹^ORCID,Xu Mingjun¹^ORCID,Zhuo Renjie²^ORCID,Liao Qi²^ORCID,Xi Yang¹^ORCID

Affiliation:

1. Diabetes Center, Zhejiang Provincial Key Laboratory of Pathophysiology, Institute of Biochemistry and Molecular Biology, Medical School of Ningbo University, Ningbo, Zhejiang, China.

2. Department of Preventative Medicine, Medical School of Ningbo University, Ningbo, Zhejiang, China.

Funder

Natural Science Foundation of Zhejiang Province

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2019.60.11.1013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis;Heliyon;2024-08

2. Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis;2023-03-24

3. The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments;Cancers;2021-04-25

4. Radiomics-based machine learning model to predict risk of death within 5-years in clear cell renal cell carcinoma patients;Computers in Biology and Medicine;2021-02

5. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma;DNA and Cell Biology;2020-06-01